• Politics
  • Diversity, equity and inclusion
  • Financial Decision Making
  • Telehealth
  • Patient Experience
  • Leadership
  • Point of Care Tools
  • Product Solutions
  • Management
  • Technology
  • Healthcare Transformation
  • Data + Technology
  • Safer Hospitals
  • Business
  • Providers in Practice
  • Mergers and Acquisitions
  • AI & Data Analytics
  • Cybersecurity
  • Interoperability & EHRs
  • Medical Devices
  • Pop Health Tech
  • Precision Medicine
  • Virtual Care
  • Health equity

Healthy Bottom Line: COVID-19 and Marijuana Laws: Why Employee Drug Positivity is on the Rise in Healthcare

Podcast

Barry Sample, PhD, director of science and technology at Quest Diagnostics, discusses the rise in drug positivity rates among healthcare employees, the reasons behind the rise, and what can be done to combat them.

On this episode of Healthy Bottom Line, Barry Sample, PhD, director of science and technology at Quest Diagnostics, discusses the rise in drug positivity rates among healthcare professionals over the course of 2020 and the consequences of drug use among employees in healthcare settings. He also talks about the role that marijuana legislation has played a role in this increase as well as some solutions to reduce positivity rates.

Related Videos
Image: Ron Southwick, Chief Healthcare Executive
Image credit: HIMSS
Related Content
© 2024 MJH Life Sciences

All rights reserved.